Summary:
New and exciting clinical trial that will help and manage better care of patients with Diabetes Mellitus type II with Chronic Kidney Disease. The side effect of the drug is to cause weight loss.
Qualified Participants Must:
• Must be type II diabetic with a HbA1c of less than 10% and receiving ACE and/or ARB for more than 4 weeks prior to screening visit
Qualified Participants May Receive:
Free study medications and free eye exam
Medical care, in regards to the study, by board certified doctor at no additional cost
Free labs for study related assessment